Redmile Group, LLC Pliant Therapeutics, Inc. Transaction History

Redmile Group, LLC

$822 Million
Q2 2025

A detailed history of Redmile Group, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,632,577 shares of PLRX stock, worth $2.74 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,632,577

Previous 2,053,559 20.5%

Holding current value

$2.74 Million

Previous $2.77 Million 31.71%

% of portfolio

0.23%

Previous 0.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.16 - $1.69 $488,339 - $711,459	-420,982 Reduced 20.5%	1,632,577 $1.89 Million
Q1 2025 May 15, 2025	SELL	$1.35 - $13.53 $1.14 Million - $11.4 Million	-841,919 Reduced 29.08%	2,053,559 $2.77 Million
Q4 2024 Feb 14, 2025	SELL	$10.55 - $15.7 $3.19 Million - $4.74 Million	-302,013 Reduced 9.45%	2,895,478 $38.1 Million
Q3 2024 Nov 14, 2024	SELL	$10.52 - $14.35 $127,292 - $173,635	-12,100 Reduced 0.38%	3,197,491 $35.8 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $1.19 Million - $1.75 Million	112,371 Added 3.63%	3,209,591 $34.5 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $5.66 Million - $7.85 Million	400,572 Added 14.85%	3,097,220 $46.1 Million
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $238,354 - $355,213	18,549 Added 0.69%	2,696,648 $48.8 Million
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $4.49 Million - $7.57 Million	-247,549 Reduced 8.46%	2,678,099 $48.5 Million
Q1 2023 May 15, 2023	SELL	$18.73 - $36.26 $17.8 Million - $34.6 Million	-952,951 Reduced 24.57%	2,925,648 $77.8 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $10.7 Million - $16 Million	-629,605 Reduced 13.97%	3,878,599 $75 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $11 Million - $34.9 Million	1,439,203 Added 46.89%	4,508,204 $94.2 Million
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $48,498 - $103,250	-11,800 Reduced 0.38%	3,069,001 $24.6 Million
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $18,927 - $38,070	-2,700 Reduced 0.09%	3,080,801 $21.6 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $1.2 Million - $2.11 Million	-72,900 Reduced 2.31%	3,083,501 $52 Million
Q2 2021 Aug 16, 2021	SELL	$28.05 - $37.69 $1.42 Million - $1.91 Million	-50,792 Reduced 1.58%	3,156,401 $91.9 Million
Q1 2021 May 17, 2021	SELL	$24.52 - $40.23 $4.44 Million - $7.29 Million	-181,183 Reduced 5.35%	3,207,193 $126 Million
Q4 2020 Feb 16, 2021	SELL	$19.89 - $32.99 $67,248 - $111,539	-3,381 Reduced 0.1%	3,388,376 $77 Million
Q3 2020 Nov 16, 2020	SELL	$21.54 - $29.53 $407,106 - $558,117	-18,900 Reduced 0.55%	3,391,757 $76.8 Million
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $72.6 Million - $120 Million	3,410,657 New	3,410,657 $111 Million

Others Institutions Holding PLRX

# of Institutions

127

Shares Held

57.7M

Call Options Held

245K

Put Options Held

86.7K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $81.8M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Pliant Therapeutics, Inc. Transaction History